© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Back in the 1930s, infectious diseases caused panic. Penicillin’s discovery made headlines, but before that, German chemists developed sulfa drugs. Among them, sulfapyridine, born in 1937, marked a turning point in medicine. British clinicians used it for pneumonia, saving lives in a time when influenza outbreaks devastated communities. Armed forces carried it through the Second World War. The legacy of that era stretches into today’s Pharmacopoeias, a testament to problem-solving driven by urgent human need.
Sulfapyridine belongs to the sulfonamide family, legendary for a sulfur-nitrogen bond that unlocked bacterial treatment well before widespread penicillin. Its broad spectrum covers various bacteria, but advances in antibiotics pulled it out of the limelight. Tablets used to fill hospital medicine cabinets, sometimes crafting a distinctive, slightly ‘medicinal’ scent that old practitioners still remember. Today, it still appears in veterinary practice and as a precursor for certain therapies—history’s workhorse refusing to retire quietly.
You recognize sulfapyridine by its white, odorless, crystalline powder that resists moisture. Chemically called 2-(p-aminophenyl)sulfonylpyridine, it comes with the molecular formula C11H11N3O2S and a molar mass of 249.29 g/mol. It has limited water solubility at room temperature but dissolves in alcohol and other organic solvents. It melts a bit above 190 degrees Celsius. If you handle the powder, it feels chalky and clings to skin, stubborn in cleanup routines.
Pharmacopeia-grade sulfapyridine sports rigid specifications. Purity must approach 99%, and manufacturers keep close tabs on degradation products like 4-aminopyridine and sulfanilamide. Labels carry batch number, purity, recommended storage temperature—safety data sheets warn to keep containers tightly closed and dry. Any visual hints of mixup—discoloration or caking—get a batch tossed. Health workers trust each bottle to meet precise standards for critical treatments, and those blueprints took refinements from years of lab notes.
The preparation involves coupling chloropyridine with sulfanilamide in alkaline medium, usually with sodium carbonate as base. Once the reaction gets underway, a mix of heat and strong stirring drives the chemical wedding, with sulfanilamide’s amino group bonding to the chloropyridine. Washing, filtration, and repeated recrystallization hone the final purity. Any chemist handling this setup will remember how attention to temperature and pH tweaks yields—too hot, product bulk degrades, too cool, crystals drop out too early.
Sulfapyridine stands up to hydrolysis under alkaline or acidic conditions. Its amine and sulfonamide groups attract the attention of organic chemists who experiment with substitutions to alter microbial selectivity or reduce toxicity. By introducing various alkyl or aryl groups at the pyridine or aniline ends, researchers created dozens of analogues, each with different pharmacological surprises. Some modifications struggled with stability, others meddled with metabolism in unpredictable ways, a reminder that in drug design, nature always keeps a few secrets until tested in real bodies.
In the history books and global regulatory lists, sulfapyridine pops up under several aliases: M&B 693, 4-Aminophenylsulfonylpyridine, and sulfapyridinum. Medical literature—old and new—references names like Sulpyron, Sulfapyridin, and others depending on the country or context. The jumble of names often requires a double-check when cross-referencing old clinical studies. But they all draw back to the same versatile molecule that made waves before antibiotics became routine.
No lab or pharmacy treats sulfapyridine lightly. Handlers wear gloves, goggles, and lab coats, since it can irritate skin and cause breathing issues in dusty conditions. Facilities include ventilation plans and spill kits nearby to neutralize powder before it floats up. Overexposure can trigger nausea, headaches, and rashes, with chronic exposure cases flagged in industrial records. Many countries list sulfapyridine as a substance requiring controlled lab access and formal inventory. Waste management routines make sure residues never hit groundwater or common trash.
Before penicillins, doctors reached for sulfapyridine first whenever bacterial pneumonia or meningitis threatened patient lives. After newer antibiotics took over, the molecule found a second wind in treating acne and rheumatoid arthritis, even as specialists weighed risks of bone marrow suppression—a warning that’s stood the test of time. Vets have used it to curb infections in livestock, horses, and poultry. In each arena, its performance underlines both the power and limitations of early antibiotic science.
Laboratories continue probing the sulfonamide backbone for next-generation drugs. Sulfapyridine gets tested as a marker for sulfonamide sensitivity in humans. Technological improvements have yielded extended-release forms and hybrid molecules. In the last decade, researchers looked at sulfapyridine’s role as a reagent in the synthesis of more complex pharmaceuticals and even as a probe in mapping drug resistance patterns among certain bacteria. No one shrugs off the lessons learned from nearly a century of clinical and chemical data collection, even as most modern therapies have moved on. Recent computational modeling explores how tiny tweaks to the aromatic rings could coax new behaviors out of the old molecule.
Red blood cell destruction, immune reactions, and kidney injury all showed up in early postmarket surveillance. More recent studies measure DNA adduct formation and link metabolic byproducts to hypersensitivity. Sulfapyridine’s ability to bind to plasma proteins influences both its bioavailability and risk of cumulative toxic reactions, especially in those with compromised metabolism such as people with NAT2 slow acetylator profiles. Decades of data help fine-tune modern diagnostics, letting clinicians predict adverse reactions based on genetic markers. Failures and successes in toxicity research led directly to today’s strict dosing and monitoring standards.
Although broad use of sulfapyridine shrank thanks to resistance and improved therapeutics, the molecule’s persistence in pharmaceutical research owes much to its teachable molecular structure. Drug designers still look at sulfonamide scaffolds for fresh antimicrobial agents, especially as multidrug-resistant infections crawl back into hospitals. Some groups investigate its roles as a linker for antibody-drug conjugates and designer prodrugs. Artificial intelligence is next in the line of tools for exploring tweakable functional groups on its classic structure. Sulfapyridine might not feature on a family doctor’s prescription pad, but in the molecular library, it keeps inspiring the leap from old cures to new.
Sulfapyridine stands as one of the earliest members of the sulfa drug family. Doctors began putting it to work during the 1930s, especially before penicillin entered hospitals and pharmacies. Back then, people relied on it to tackle stubborn outbreaks of bacterial infections such as pneumonia and urinary tract infections. Even in my university days, we learned how sulfa antibiotics changed the course of modern medicine. The stories we read, some tragic, some triumphant, remind us of how desperate people became for cures. Nobody who survived the years before modern antibiotics forgets the feeling of hope these drugs brought.
Doctors don’t grab sulfapyridine as often as they used to. Bacteria started to adapt, building resistance. Newer antibiotics like trimethoprim-sulfamethoxazole and amoxicillin pushed sulfapyridine down the list. These new drugs work faster and cause fewer side effects. Many hospitals have tucked sulfapyridine away, making room for medicines with a better safety record. Despite this, its story isn’t over yet. Some forms of inflammatory bowel disease, especially ulcerative colitis, respond to a related drug called sulfasalazine. The magic of sulfasalazine comes from splitting into two parts in the body: 5-aminosalicylic acid (which calms gut inflammation) and sulfapyridine. Here, sulfapyridine works quietly, playing a supporting role for millions who struggle with chronic gut pain.
Anyone who considers a drug like sulfapyridine deserves straight talk about safety. Sulfa allergies pop up in a small percentage of folks, and when they do, reactions can spin out of control. Fever, skin rashes, and even life-threatening syndromes lurk in the shadows. People with a specific enzyme deficiency (G6PD deficiency) can face anemia if they take sulfapyridine. Doctors watch for these risks and choose sulfapyridine only if other options make less sense. In my own clinic rotations, we rarely saw a prescription for pure sulfapyridine, but sulfa allergies remained on every patient’s chart—nobody wanted to get caught off guard.
Antibiotic resistance deserves everyone’s attention. Old drugs like sulfapyridine stopped working for more people because of this problem. Bacteria swap genes like trading cards, quickly outsmarting our best treatments. One solution? Reserve antibiotics for the fights we can’t win any other way, and back up the doctors who decide to hold back from writing a prescription. Sometimes, even a sturdy old drug like sulfapyridine just isn’t the right answer. Patients and caregivers need open conversations, clear instructions, and strong follow-up if complications pop up. Medical teams must share knowledge and learn from every case, not just textbook success stories.
Sulfapyridine may have faded from the front lines, but it carved a legacy none of us can ignore. With every headline about antibiotic shortages or superbugs, its story matters all over again. The lessons learned—about safety, adaptation, and stewardship—shape how medicine tackles infection and chronic disease, every single day. For anyone whose life depends on effective treatment, that counts for a lot.
Sulfapyridine isn’t the new kid on the block. My grandparents talked about these “sulfa drugs” and how they changed medicine back in the 1930s and ’40s. Doctors handed out sulfapyridine to fight nasty bacterial infections before penicillin hit the shelves. People still use it today—especially in certain arthritis meds like sulfasalazine—so these side effects stick around in pharmacies and family medicine cabinets.
Ask around in any clinic, and folks mention stomach problems first. Nausea or an upset gut tends to show up soon after someone starts on it. Some people talk about a nagging headache or a fever that just won’t quit, so it’s pretty clear the drug can take its toll on the body’s comfort level. Rashes are a biggie for these older antibiotics. A simple itchy patch might just be an irritation, but red spots and peeling skin can mean an allergic reaction most doctors won’t ignore.
Many patients describe feeling lightheaded, tired, or downright wiped out. I’ve even seen people develop a sort of sunburn just from stepping outdoors, since sulfapyridine can make skin extra sensitive to sunlight. That’s a fact not everyone expects when picking up a prescription for an infection.
Sulfapyridine’s biggest risks show up in the doctor’s warning sheet: blood problems. People can get anemia when their body stops making enough healthy red blood cells. The pattern usually starts off with bruising, infections, or frequent nosebleeds. From stories I’ve heard and cases I’ve read, folks with a genetic condition called G6PD deficiency have to run the other way from this medicine—just a short dose can trigger really severe anemia.
There’s also something called Stevens-Johnson syndrome, where the skin and mucous membranes blister up. Thankfully, that’s rare. Still, if someone’s lips swell or they start to get blisters and mouth sores, that’s not something to try and sleep off at home. People should seek help right away.
Plenty of people try to tough out side effects, blaming everything from a new workout routine to bad takeout food. In my own family, we once missed an allergic reaction to an older sulfa drug until the rash spread across both arms. That put us straight in the ER line. Stories like this play out way too often.
Doctors need to know what’s going on to spot trouble before it grows. The FDA says you should stop taking the drug and call your provider right away if you see rashes, bruising, or get trouble drinking fluids. These aren’t minor inconveniences—they’re signs your body wants a break from the medicine.
Better education could make a big difference. Pharmacists who take a minute to describe what side effects look like—using plain talk, not medical jargon—help patients notice early warnings and act fast. At home, keeping a list of past allergies or weird medication reactions in the medicine cabinet helps families (and paramedics) know what to watch for. If your doctor offers an alternative drug and you’ve had odd reactions in the past, don’t just nod and move along. Ask for details and keep those records handy.
Sulfapyridine has been around for decades, earning a seat in the pharmacy for people with bacterial infections and as part of some treatments for chronic conditions like rheumatoid arthritis. Although newer drugs have replaced it in many cases, doctors in specific regions or special situations still turn to sulfapyridine, especially as an alternative to sulfasalazine during shortages or for certain kinds of infections.
The number on the pill bottle isn’t random. Doctors look closely at what’s being treated, kidney function, age, and—often overlooked—other medicines in someone’s daily routine. For infections, a typical adult may start out taking 1 gram, four times per day, spaced as evenly as life allows. Adjustments happen based on blood test results, symptoms, and side effects. Teens or children get a dose based on weight, not age, because a twelve-year-old six-footer handles medication a lot differently than a petite nine-year-old, even if both fill a similar prescription.
Folks using sulfapyridine for long-term conditions like arthritis usually see lighter daily totals shared among smaller doses—aimed at keeping the drug steady in their bloodstream. Some build up to their final daily dose, to help the body adjust and avoid stomach trouble or allergic reactions. People want symptom relief, not a race to the hospital, so sticking with a doctor’s plan matters.
Skipping or doubling up on pills throws a wrench in drug levels. Too little, and bacteria come back with a vengeance, getting smarter and harder to kill next time. Too much, and real risks pop up. High levels of sulfapyridine put the kidneys to work and can trigger headaches, serious skin rashes, or, in rare cases, blood problems. Hydration keeps these risks lower because plenty of water helps flush the leftovers through the body. Anyone drinking less or sweating buckets needs to tell their doctor; sometimes the plan needs a tweak.
Not everyone can use this medicine. People allergic to other “sulfa” drugs usually can’t take it—reactions can turn dangerous. Anyone with trouble making urine, major liver problems, or a history of severe skin reactions from similar pills gets crossed off the list. Lab tests, especially checking kidney and liver function, guide doctors before anyone extends a prescription beyond just a few days.
Pregnant people, those breastfeeding, or anyone managing multiple complicated health conditions should press pause and check with a healthcare provider because some risks skyrocket in these groups.
Food in the stomach can lower the risk of stomach trouble. I learned this after taking a dose before breakfast once—bad move. Drinking a full glass of water each time helps keep the medication moving and the kidneys happy. Dosing at the same hours every day links the medicine to a routine, like meals or teeth-brushing, making missed doses less likely. If a dose slips by, taking it as soon as possible matters, but not if the next one’s almost due. Don’t double up—let the schedule flow back to normal.
People often hesitate to mention side effects or mix-ups in dosing. Open talk helps everyone get better, safer care. Pharmacists and doctors track drug allergies, cross-check interactions, and remind patients what “normal” side effects look like—my own doctor once flagged a small rash early, catching a problem before it got serious. These real conversations make all the difference.
I’ve seen firsthand how easy it is for folks to gloss over medication warnings and end up dealing with health hiccups down the road. Sulfapyridine sits among those older antibiotics that still play a role, especially for conditions like rheumatoid arthritis and some infections. At clinics, I’ve met patients who recall its use from decades ago, while others start it as part of sulfasalazine for chronic illness. Either way, drug safety never gets old.
Anybody with a known allergy to sulfa drugs needs to keep a safe distance from sulfapyridine. Rashes, swelling, or even life-threatening reactions can happen quickly. The World Health Organization points out that allergic responses to sulfa meds can lead to severe outcomes and hospitalizations. I’ve spoken with people who shrugged off “just a rash,” only to discover it could turn much worse. A history of allergy deserves respect, and anything that hints at hypersensitivity calls for a doctor’s input without delay.
Sulfapyridine can lead to blood cell changes—low white cells or platelets, for example. The risk jumps for folks already struggling with bone marrow conditions or those taking other medicines that suppress immunity. One neighbor of mine needed regular blood work just to stay on course during treatment. Docs know this risk well, so they often ask for complete blood count checks while someone takes the drug. Missing these checks puts people at risk for infection or unexpected bleeding, big red flags that call for quick action.
Liver and kidney health play a big role in how the body handles sulfapyridine. If either organ takes a hit, the drug can build up, leading to headaches, dizziness, or even confusion. When the kidneys aren’t working at full speed, toxic levels can creep up quietly. Patients with liver disease could also see symptoms worsen. For those with chronic conditions, care teams need to weigh potential benefits against these real risks. I’ve seen schedules adjusted and doses lowered to pave the safest route forward.
Drug interactions with sulfapyridine come up more often than people expect. Take methotrexate, for example. Used by many with arthritis, it can raise the toxic potential of sulfapyridine. The Food and Drug Administration cautions about mixing these two, since the risk for liver problems and bone marrow suppression goes up. Another example: warfarin, a blood thinner, can act up when paired with sulfapyridine. The risk of bleeding grows, so folks get stuck with frequent lab visits. I recall several cases where families needed constant reminders on adjusting the schedule and watching for side effects.
Medicine cabinet safety isn’t just about remembering to take a pill. Patients can help by tracking all medicines including over-the-counter items and supplements. Pharmacists serve as another line of defense, often catching interactions doctors or patients miss. Electronic health records help, but simple communication works wonders. Bringing a medication list to every visit can save hassle and prevent errors. Conversation between patient and provider builds trust and helps root out possible problems long before they start.
As we see more people living longer with complex health issues, combining drugs like sulfapyridine with other agents becomes common. Listening to stories, sharing clear advice, and keeping a close watch on laboratory results can turn potential trouble into smoother, safer care. In my own experience, the more open the discussion about risks, the fewer surprises people face down the line.
Sulfapyridine belongs to the sulfonamide family—an old class of antibiotics, once a leading option before newer drugs took over. Sometimes it still pops up for rare infections or certain autoimmune skin conditions. For anyone pregnant or breastfeeding, any drug passes through an extra level of scrutiny. Every parent wants answers: Does it put the baby at risk? Can I still treat what’s hurting me?
Pregnancy turns the body into an unpredictable laboratory. Blood volume shifts, kidneys work overtime, and anything swallowed ends up having an influence far beyond just one adult. With sulfapyridine, data from years of use have highlighted a few red flags. Sulfonamides cross the placenta. This exposes the unborn child, especially later in pregnancy when the baby’s liver can’t clear drugs as fast. Sulfa drugs have been linked to jaundice and even dangerous changes to the blood—things like kernicterus, a kind of brain damage linked to very high bilirubin levels.
Strongest danger seems to show up if a pregnant person takes sulfonamides in the last trimester, when bilirubin risk spikes. No one wants to face the choice between an untreated infection and a possible risk for their baby. So, doctors try to steer away from sulfapyridine, especially after 32 weeks. Some infections might push the issue, but usually there are safer alternatives on the table. More people might remember trimethoprim-sulfamethoxazole (Bactrim), another cousin in the same family, which gets more warnings for the same reasons. Sulfapyridine isn’t the top pick and rarely comes up unless nothing else works.
Nursing mothers carry the extra job of worrying about what ends up in breast milk. Sulfonamides, including sulfapyridine, do get passed into milk. This means babies under two months could be exposed, and they can’t process the drug like older infants or adults. There’s a higher risk for certain health conditions, for example, if the baby was premature, had jaundice, or carries a specific enzyme deficiency called G6PD. Any sulfa drug raises the stakes in these babies, where even a regular dose can lead to dangerous anemia or abnormal blood chemistry.
I have seen new parents, barely sleeping, pick up every medication label looking for big words. A lot of them ask pharmacists before doctors even outline the choices, because trust in lived experience matters. Experts at the American Academy of Pediatrics note sulfonamides are not the best choice for nursing mothers of vulnerable babies—think newborns, preemies, or those still fighting off jaundice. Safer antibiotics nearly always exist, and folks with choices usually pick something with a cleaner safety record.
Medicine keeps a long list of antibiotics with a better safety margin for use in pregnancy and breastfeeding. Penicillins and cephalosporins usually win out for infections. If a rare situation pops up—like a resistant skin disease—doctors might have to weigh risk versus benefit in conversation with the family. No one wants to tough it out with pain or untreated infection. Open, careful talk around all the options, with up-to-date studies in hand, leads to better decisions. Sometimes the answer changes as new research comes in; that keeps everyone honest.
Before taking any drug during pregnancy or nursing, a conversation with a doctor or pharmacist brings answers that fit the situation. Resources like LactMed, review by real specialists, and personal experience all add up. No one tool or old guideline stands alone. Every parent’s experience matters, and every baby’s safety counts just as much as the parent’s well-being.
| Names | |
| Preferred IUPAC name | 4-Amino-N-(pyridin-2-yl)benzenesulfonamide |
| Other names |
M&B 693 Sulfapyridin Sulfapiridina Sulphapyridine |
| Pronunciation | /ˌsʌl.fə.pəˈraɪ.diːn/ |
| Identifiers | |
| CAS Number | 144-83-2 |
| 3D model (JSmol) | `3D(SDF,open,C11H11N3O2S;.CC1=CC=CC=C1N=C1N=CC=C(S(N)(=O)=O)C1)` |
| Beilstein Reference | 1718730 |
| ChEBI | CHEBI:9359 |
| ChEMBL | CHEMBL1400 |
| ChemSpider | 2784 |
| DrugBank | DB00259 |
| ECHA InfoCard | 100.004.839 |
| EC Number | 3.5.4.9 |
| Gmelin Reference | 74160 |
| KEGG | C07625 |
| MeSH | D013434 |
| PubChem CID | 16416 |
| RTECS number | WO7000000 |
| UNII | HAA7Q7B8FY |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID8021205 |
| Properties | |
| Chemical formula | C11H11N3O2S |
| Molar mass | 249.29 g/mol |
| Appearance | Yellowish white crystalline powder |
| Odor | Odorless |
| Density | 1.382 g/cm³ |
| Solubility in water | Slightly soluble in water |
| log P | 0.89 |
| Vapor pressure | 5.78E-9 mmHg at 25°C |
| Acidity (pKa) | 7.4 |
| Basicity (pKb) | 7.45 |
| Magnetic susceptibility (χ) | -61.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.655 |
| Viscosity | Viscous liquid |
| Dipole moment | 4.85 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 299.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -40.8 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3886 kJ mol⁻¹ |
| Pharmacology | |
| ATC code | J01EB03 |
| Hazards | |
| Main hazards | Causes eye, skin, and respiratory tract irritation. May cause allergic skin reaction. Harmful if swallowed. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | Precautionary statements: "P261, P264, P270, P301+P312, P304+P340, P312, P330, P405, P501 |
| NFPA 704 (fire diamond) | 2-1-0 |
| Flash point | 170°C |
| Autoignition temperature | 605°C |
| Lethal dose or concentration | LD50 oral rat 7000 mg/kg |
| LD50 (median dose) | LD50: 8200 mg/kg (oral, rat) |
| NIOSH | NA0450000 |
| PEL (Permissible) | 15 mg/m³ |
| REL (Recommended) | 10 mg/kg/day |
| Related compounds | |
| Related compounds |
Sulfasalazine Sulfanilamide Sulfadiazine Sulfamethazine |
